Beyfortus 50 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FFF4Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,434
Award facts
- Contract value 100% obligated
- $14,433.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Beyfortus 50 mg/0.5 mL syringes with a ceiling value of $14,433.73. Beyfortus is a monoclonal antibody used for respiratory syncytial virus (RSV) prevention, particularly in infants and young children. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order expected to be completed by October 24, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio supplying pharmaceuticals and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive experience fulfilling federal medical procurement requirements through DLA demonstrates its capability to meet military healthcare supply needs across multiple therapeutic domains. This award reflects the continued reliance on AmerisourceBergen as a critical vendor within the federal medical supply chain, particularly for specialized pharmaceutical products supporting military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FFF4Y?
SPE2DR26FFF4Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DR26FFF4Y worth?
The government has obligated $14,434 on SPE2DR26FFF4Y.
Is contract SPE2DR26FFF4Y an order under another contract?
Yes. SPE2DR26FFF4Y is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFF4Y competed?
The extent of competition for SPE2DR26FFF4Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award